Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹644 Cr.
Stock P/E
136.8
P/B
7.2
Current Price
₹365
Book Value
₹ 50.9
Face Value
10
52W High
₹381.5
52W Low
₹ 147.4
Dividend Yield
—

Saakshi Med & Panels Overview

Business

Saakshi Medtech & Panels Ltd. is an Indian manufacturing company operating in two distinct sectors: electrical equipment and medical devices.

Electrical Control Panels (Panels Division): The company designs, manufactures, and supplies various types of electrical control panels, including Motor Control Centers (MCC), Power Control Centers (PCC), Automatic Power Factor Correction (APFC) panels, and Variable Frequency Drive (VFD) panels. These panels are critical for power distribution, motor control, and automation in diverse applications across infrastructure, industrial (e.g., Oil & Gas, Pharma, Steel, Chemical), and residential sectors.

Medical Devices (Medtech Division): Saakshi also manufactures and assembles medical diagnostic imaging equipment. This primarily includes X-ray machines, Digital Radiography (DR) systems, and related accessories such as X-ray generators, stands, and tables. Their offerings cater to the healthcare industry for diagnostic purposes.

The company generates revenue by selling these manufactured products to industrial clients, infrastructure project developers, and healthcare providers.

Revenue Mix

The company operates through two core business divisions:

Panels Division: Focuses on the manufacturing and sale of electrical control panels.

Medtech Division: Concentrates on the manufacturing and assembly of medical X-ray machines and associated equipment.

Specific revenue contribution percentages for each segment are not publicly detailed in general company overviews. However, both divisions are core to the company's operational strategy and product offerings.

Industry

Electrical Control Panels: This industry in India is highly fragmented, comprising a mix of unorganized players, regional manufacturers, and larger national/international companies. Saakshi positions itself by offering customized solutions, leveraging its in-house manufacturing capabilities, and emphasizing quality for industrial and infrastructure projects. Competition is driven by product quality, customization flexibility, delivery times, and pricing.

Medical Devices (X-ray/Imaging): The Indian medical device market, particularly for imaging equipment, is growing but competitive. It features global multinational corporations known for advanced technology, alongside a growing number of domestic manufacturers. Saakshi, with its "Make in India" focus, likely targets a segment that values local manufacturing, potentially cost-effectiveness, and adherence to domestic support and regulatory requirements, serving smaller healthcare facilities and government initiatives.

MOAT

Saakshi Medtech & Panels Ltd. does not exhibit strong, wide moats typical of dominant market leaders but has several operational advantages:

In-house Manufacturing & Customization: The ability to design and produce tailored electrical panels and potentially customize medical equipment allows flexibility and responsiveness to client needs.

"Make in India" Alignment: This focus, especially in the medical device segment, can be a competitive edge, benefiting from government procurement preferences and potentially lower manufacturing costs compared to imports.

Quality & Certifications: Adherence to quality standards (e.g., ISO, CE for medical devices where applicable) helps build trust and credibility with clients in critical sectors.

Client Relationships: For smaller companies, building strong, long-term relationships with industrial clients and healthcare providers can lead to repeat business.

The company does not appear to possess significant proprietary technology, dominant brand equity, or substantial economies of scale compared to larger incumbents in either industry.

Growth Drivers

Infrastructure Development: Ongoing and planned infrastructure projects in India (e.g., power generation and distribution, smart cities, industrial corridors) will drive consistent demand for electrical control panels.

Industrial Modernization & Automation: Increasing adoption of automation and modern control systems across various industries to enhance efficiency and productivity will boost demand for advanced electrical panels.

Healthcare Sector Expansion: Growing healthcare spending, expansion of public and private healthcare facilities (hospitals, clinics) across India, and increasing awareness of diagnostics will fuel demand for X-ray and Digital Radiography systems.

Government Initiatives: Schemes like "Make in India" and Production Linked Incentive (PLI) schemes for manufacturing can provide tailwinds for domestic players in both electrical equipment and medical devices.

Technological Upgrades: The ongoing shift from conventional X-ray to digital radiography systems presents opportunities for new equipment sales and upgrades.

Risks

Economic Downturn: A slowdown in economic growth, industrial output, or government infrastructure spending can directly reduce demand for electrical panels.

Intense Competition & Pricing Pressure: Both the electrical equipment and medical device markets are highly competitive, potentially leading to pricing pressures and erosion of profit margins.

Raw Material Price Volatility: Fluctuations in the cost of key raw materials such as copper, steel, and electronic components can significantly impact manufacturing costs and profitability if not effectively managed or passed on to customers.

Technological Obsolescence: Rapid advancements in medical imaging technology or electrical control systems could render existing product lines less competitive if the company fails to innovate or invest in R&D.

Project-Based Revenue Volatility: The electrical panel business can be project-oriented, leading to irregular revenue streams and challenges in financial forecasting.

Regulatory Changes: Changes in industry standards, safety regulations for electrical equipment, or healthcare device regulations could necessitate costly compliance updates.

Management & Ownership

Saakshi Medtech & Panels Ltd. is an SME company listed on NSE Emerge, typically indicating a promoter-driven management structure. Mr. Chandrashekhar Rane and Mrs. Vaishali Rane are identified as the promoters of the company. As is common with SME listings, promoter holding likely constitutes a significant portion of the total equity, ensuring strong oversight and strategic direction. The specific current ownership percentages would be detailed in the company's latest shareholding pattern filings with the exchange.

Outlook

Saakshi Medtech & Panels Ltd. operates in attractive sectors with strong underlying growth drivers in India, namely infrastructure development, industrial modernization, and expanding healthcare access. The company's dual-segment focus provides a degree of diversification, potentially mitigating risks associated with reliance on a single market. Its "Make in India" emphasis could be advantageous in government procurement and in capturing a value-conscious segment of the market for both electrical panels and medical devices.

However, the company faces stiff competition from both established domestic players and larger multinational corporations across its segments. As a smaller entity, it may have limitations in terms of R&D budgets, marketing spend, and economies of scale compared to its larger rivals. Success will hinge on its ability to consistently deliver quality, customized, and cost-effective solutions, manage supply chain and raw material price volatility, and adapt to technological advancements within its niche. The long-term performance will largely be influenced by its operational efficiency, innovation efforts, and effective navigation of competitive pressures while capitalizing on India's sustained economic and healthcare growth.

Saakshi Med & Panels Share Price

Live · NSE · Inception: 2009
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Saakshi Med & Panels Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Saakshi Med & Panels Profit & Loss

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 61 60 92 122 122 92
Other Income 0 0 0 0 1 1
Total Income 62 60 92 122 123 93
Total Expenditure 50 54 76 101 102 82
Operating Profit 12 6 16 21 21 11
Interest 2 1 1 1 2 0
Depreciation 2 2 2 3 4 4
Exceptional Income / Expenses 0 0 0 0 0 0
Profit Before Tax 8 3 13 17 15 7
Provision for Tax 2 1 3 4 4 2
Profit After Tax 6 2 9 12 11 5
Adjustments 0 0 0 0 0 0
Profit After Adjustments 6 2 9 12 11 5
Adjusted Earnings Per Share 4.5 1.6 7.2 9.5 6.4 2.7

Saakshi Med & Panels Balance Sheet

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 18 20 30 42 93 98
Minority's Interest 0 0 0 0 0 0
Borrowings 8 8 7 7 15 14
Other Non-Current Liabilities 1 1 0 3 2 0
Total Current Liabilities 22 27 28 41 21 19
Total Liabilities 48 56 65 93 131 131
Fixed Assets 22 22 26 34 62 60
Other Non-Current Assets 3 3 3 3 3 17
Total Current Assets 23 31 36 56 66 54
Total Assets 48 56 65 93 131 131

Saakshi Med & Panels Cash Flow

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 2 3 1 3 15
Cash Flow from Operating Activities 11 0 11 11 7 3
Cash Flow from Investing Activities -6 -1 -5 -11 -31 -15
Cash Flow from Financing Activities -3 2 -7 2 36 -1
Net Cash Inflow / Outflow 2 1 -1 2 12 -12
Closing Cash & Cash Equivalent 2 3 1 3 16 3

Saakshi Med & Panels Ratios

# Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.45 1.62 7.21 9.52 6.4 2.67
CEPS(Rs) 5.68 2.92 8.54 11.56 8.58 4.87
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 13.87 15.49 22.97 32.49 52.86 55.53
Core EBITDA Margin(%) 18.07 9.82 17.08 14.36 13.84 9.57
EBIT Margin(%) 16.2 7.73 15.33 12.61 11.67 6.49
Pre Tax Margin(%) 12.38 5.23 13.81 11.58 10.47 6.12
PAT Margin (%) 9.45 3.52 10.24 8.64 7.92 4.37
Cash Profit Margin (%) 12.05 6.36 12.12 10.49 10.61 7.98
ROA(%) 11.97 4.04 15.51 15.62 10.1 3.6
ROE(%) 32.09 11.03 37.51 34.33 16.68 4.92
ROCE(%) 26.8 11.68 31.77 33.3 19.19 6.16
Receivable days 62.16 76.63 64.04 51.48 51.46 66.41
Inventory Days 46.05 55.88 47.7 47.17 57.93 71.27
Payable days 73.4 82.88 74.36 78.35 69.49 54.28
PER(x) 0 0 0 0 35.03 48.1
Price/Book(x) 0 0 0 0 4.24 2.31
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) 0.32 0.37 0.19 0.16 3.27 2.61
EV/Core EBITDA(x) 1.72 3.45 1.12 0.94 19.43 22.15
Net Sales Growth(%) 0 -2.43 53.21 33.28 -0.17 -24.14
EBIT Growth(%) 0 -53.42 203.68 28.75 -7.8 -58.03
PAT Growth(%) 0 -63.63 345.43 32.01 -8.65 -58.34
EPS Growth(%) 0 -63.63 345.43 32 -32.74 -58.34
Debt/Equity(x) 1.05 1.09 0.55 0.48 0.19 0.18
Current Ratio(x) 1.04 1.15 1.32 1.37 3.17 2.92
Quick Ratio(x) 0.68 0.75 0.83 0.79 2.12 1.83
Interest Cover(x) 4.24 3.09 10.1 12.2 9.7 17.26
Total Debt/Mcap(x) 0 0 0 0 0.05 0.08

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -25% 0% +9% —
Operating Profit CAGR -48% -12% -2% —
PAT CAGR -55% -18% -4% —
Share Price CAGR +115% +34% — —
ROE Average +5% +19% +21% +23%
ROCE Average +6% +20% +20% +21%

Saakshi Med & Panels Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 74.82 %
FII 0.07 %
DII (MF + Insurance) 0.27 %
Public (retail) 24.84 %
# Sep 2023 Dec 2023 Mar 2024 Sep 2024 Dec 2024 Mar 2025 Sep 2025 Mar 2026 Jun 2026
Promoter 73.6373.6373.6373.6373.6373.6373.8974.8274.82
FII 31.630.030.110.10.10.190.070.07
DII 5.523.731.791.541.511.591.320.30.27
Public 17.8521.0124.5524.7324.7624.6924.624.8124.84
Others 000000000
Total 100100100100100100100100100

Saakshi Med & Panels Peer Comparison

Electric Equipment Edit Columns

Saakshi Med & Panels Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Saakshi Med & Panels Pros & Cons

Pros

  • Debtor days have improved from 69.49 to 54.28days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 7.2 times its book value.
  • The company has delivered a poor profit growth of -3% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp